研究微乳液成分的影响:酮康唑的体外渗透。

Investigating effect of microemulsion components: In vitro permeation of ketoconazole.

机构信息

Indukaka Ipcowala College of Pharmacy, Vallabh Vidyanagar, India.

出版信息

Pharm Dev Technol. 2011 Jun;16(3):250-8. doi: 10.3109/10837451003610845. Epub 2010 Feb 10.

Abstract

The purpose of this study was to evaluate the effect of oil, surfactant/co-surfactant mixing ratios and water on the in vitro permeation of ketoconazole (KTZ) applied in O/W microemulsion vehicle through intact rat skin. Lauryl Alcohol (LA) was screened as the oil phase of microemulsions, due to a good solubilizing capacity of the microemulsion system. The pseudo-ternary phase diagrams for microemulsion regions were constructed using LA as the oil, Labrasol (Lab) as the surfactant (S) and ethanol (EtOH) as the cosurfactant (CoS). The formulation which showed a highest permeation rate of 54.65 ± 1.72 µg/cm(2)/h(1) and appropriate physico-chemical properties was optimized as containing 2% KTZ, 10% LA, 20% Lab/EtOH (1:1) and 68% double distilled water (w/w). The efficiency of microemulsion formulation in the topical delivery of KTZ was dependent upon the contents of water and LA as well as Lab/EtOH mixing ratio. It was concluded that the percutaneous absorption of KTZ from microemulsions was enhanced with increasing the LA and water contents, and with decreasing the Lab/EtOH ratio in the formulation. Candida albicans was used as a model fungus to evaluate the antifungal activity of the best formula achieved, which showed the widest zone of inhibition as compared to KTZ reference. The studied microemulsion formulation showed a good stability for a period of three months. Histopathological investigation of rat skin revealed the safety of microemulsion formulations for topical use. These results indicate that the studied microemulsion formulation might be a promising vehicle for topical delivery of KTZ.

摘要

本研究旨在评估油、表面活性剂/共表面活性剂混合比以及水对酮康唑(KTZ)经皮渗透的影响,研究对象为应用于 O/W 微乳载体的完整大鼠皮肤。由于对微乳体系具有良好的增溶能力,月桂醇(LA)被筛选为微乳的油相。采用 LA 作为油相、Labrasol(Lab)作为表面活性剂(S)和乙醇(EtOH)作为共溶剂(CoS)构建微乳区域的拟三元相图。筛选出具有最高渗透速率 54.65 ± 1.72 µg/cm(2)/h(1) 和适当物理化学性质的配方,其最佳配方为含有 2% KTZ、10% LA、20% Lab/EtOH(1:1)和 68%双蒸水(w/w)。微乳配方对 KTZ 的局部递送效率取决于水和 LA 的含量以及 Lab/EtOH 的混合比。结果表明,随着 LA 和水含量的增加以及配方中 Lab/EtOH 比例的降低,酮康唑从微乳中的经皮吸收增强。用白色念珠菌作为模型真菌来评估最佳配方的抗真菌活性,与 KTZ 参考品相比,最佳配方显示出最宽的抑菌带。研究的微乳制剂在三个月的时间内表现出良好的稳定性。大鼠皮肤的组织病理学研究表明,微乳制剂可安全用于局部应用。这些结果表明,所研究的微乳制剂可能是酮康唑局部递药的一种有前途的载体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索